Tagrisso 40 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F47UU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $73,843
Award facts
- Contract value 100% obligated
- $73,842.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $73,842.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 28, 2026, for the supply of Tagrisso 40 mg tablets in quantities of 30. This non-set-aside award is scheduled for completion by February 19, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. Tagrisso is a prescription oncology medication, reflecting the broader pharmaceutical supply role that AmerisourceBergen maintains within the federal healthcare system, particularly for military and veteran populations.
This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s (UEI: NWEGNLYTBDW4) substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen's consistent receipt of non-set-aside, competitively awarded contracts demonstrates its capability to meet federal procurement requirements for essential pharmaceutical commodities across the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F47UU?
SPE2DR26F47UU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F47UU worth?
The government has obligated $73,843 on SPE2DR26F47UU.
Is contract SPE2DR26F47UU an order under another contract?
Yes. SPE2DR26F47UU is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47UU competed?
The extent of competition for SPE2DR26F47UU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award